Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context

Summary: Background: Growing evidence suggests that exposure to per- and polyfluoroalkyl substances (PFAS) are linked to an increased risk of type 2 diabetes (T2D); however, the effect of PFAS mixtures and underlying mechanisms are not well understood. We examined the associations between exposure...

Full description

Saved in:
Bibliographic Details
Main Authors: Vishal Midya, Meizhen Yao, Elena Colicino, Dinesh Barupal, Xiangping Lin, Chris Gennings, Leda Chatzi, Veronica Wendy Setiawan, Ruth J.F. Loos, Ryan W. Walker, Douglas I. Walker, Damaskini Valvi
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396425002828
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399012186128384
author Vishal Midya
Meizhen Yao
Elena Colicino
Dinesh Barupal
Xiangping Lin
Chris Gennings
Leda Chatzi
Veronica Wendy Setiawan
Ruth J.F. Loos
Ryan W. Walker
Douglas I. Walker
Damaskini Valvi
author_facet Vishal Midya
Meizhen Yao
Elena Colicino
Dinesh Barupal
Xiangping Lin
Chris Gennings
Leda Chatzi
Veronica Wendy Setiawan
Ruth J.F. Loos
Ryan W. Walker
Douglas I. Walker
Damaskini Valvi
author_sort Vishal Midya
collection DOAJ
description Summary: Background: Growing evidence suggests that exposure to per- and polyfluoroalkyl substances (PFAS) are linked to an increased risk of type 2 diabetes (T2D); however, the effect of PFAS mixtures and underlying mechanisms are not well understood. We examined the associations between exposure to PFAS mixture with later T2D diagnosis and underlying metabolic dysregulations. Methods: We conducted a nested case–control study within BioMe, an electronic health record-linked biobank of >65,000 patients seeking primary care at Mount Sinai Hospital, New York, since 2007. After excluding prevalent T2D cases at baseline, we selected 180 incident T2D cases (33% African Americans, 33% Hispanics, 33% Whites) and 180 age, sex, and ancestry-matched T2D-free controls. In prediagnostic plasma collected at baseline (∼6 years before diagnosis), we quantified seven PFAS and untargeted metabolomic profiles. We used Weighted Quantile Sum regression to evaluate the PFAS mixture association with the odds for incident T2D. We analysed the associations between ∼650 annotated metabolites and the PFAS mixture or T2D odds using Hierarchical Bayesian Weighted Quantile Sum and logistic regression, respectively, adjusting for matching factors and other confounders. Pathway enrichment analyses were performed using Mummichog. Findings: Each tertile increase in the PFAS mixture was associated with higher odds of incident T2D (OR [95% CI] = 1.31 [1.01, 1.70]), with Perfluorooctane Sulfonate (PFOS) having the highest contribution to this association. Metabolites associated with both the PFAS mixture and T2D odds were 5-hydroxytryptophan, glucoheptulose, and sulfolithocholylglycine; the associations with sulfolithocholylglycine survived multiple testing corrections. Pathways associated with both the PFAS mixture and T2D were glutamate metabolism, arginine and proline metabolism, and drug metabolism—cytochrome p450. Interpretation: Exposure to PFAS mixtures may be associated with increased odds for T2D in multiethnic populations via dysregulations in amino acid and drug metabolism. Larger investigations in multiethnic populations are required to elucidate the potential PFAS contribution to metabolic alterations and T2D risk. Funding: National Institutes of Health (R01ES033688, P30ES023515, R21ES035148, R35ES030435, R01ES032242, R01ES034521, R01ES029944, R01ES030364, U01HG013288, R21ES037112 and P30ES007048).
format Article
id doaj-art-d79fe7f4dff943cc9ad238e11415bf7a
institution Kabale University
issn 2352-3964
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj-art-d79fe7f4dff943cc9ad238e11415bf7a2025-08-20T03:38:26ZengElsevierEBioMedicine2352-39642025-08-0111810583810.1016/j.ebiom.2025.105838Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in contextVishal Midya0Meizhen Yao1Elena Colicino2Dinesh Barupal3Xiangping Lin4Chris Gennings5Leda Chatzi6Veronica Wendy Setiawan7Ruth J.F. Loos8Ryan W. Walker9Douglas I. Walker10Damaskini Valvi11Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Corresponding author.Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Genetics, Stanford University School of Medicine, Palo Alto, CA, USADepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USADepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAThe Charles Bronfman Institutes for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USAGangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USADepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USASummary: Background: Growing evidence suggests that exposure to per- and polyfluoroalkyl substances (PFAS) are linked to an increased risk of type 2 diabetes (T2D); however, the effect of PFAS mixtures and underlying mechanisms are not well understood. We examined the associations between exposure to PFAS mixture with later T2D diagnosis and underlying metabolic dysregulations. Methods: We conducted a nested case–control study within BioMe, an electronic health record-linked biobank of >65,000 patients seeking primary care at Mount Sinai Hospital, New York, since 2007. After excluding prevalent T2D cases at baseline, we selected 180 incident T2D cases (33% African Americans, 33% Hispanics, 33% Whites) and 180 age, sex, and ancestry-matched T2D-free controls. In prediagnostic plasma collected at baseline (∼6 years before diagnosis), we quantified seven PFAS and untargeted metabolomic profiles. We used Weighted Quantile Sum regression to evaluate the PFAS mixture association with the odds for incident T2D. We analysed the associations between ∼650 annotated metabolites and the PFAS mixture or T2D odds using Hierarchical Bayesian Weighted Quantile Sum and logistic regression, respectively, adjusting for matching factors and other confounders. Pathway enrichment analyses were performed using Mummichog. Findings: Each tertile increase in the PFAS mixture was associated with higher odds of incident T2D (OR [95% CI] = 1.31 [1.01, 1.70]), with Perfluorooctane Sulfonate (PFOS) having the highest contribution to this association. Metabolites associated with both the PFAS mixture and T2D odds were 5-hydroxytryptophan, glucoheptulose, and sulfolithocholylglycine; the associations with sulfolithocholylglycine survived multiple testing corrections. Pathways associated with both the PFAS mixture and T2D were glutamate metabolism, arginine and proline metabolism, and drug metabolism—cytochrome p450. Interpretation: Exposure to PFAS mixtures may be associated with increased odds for T2D in multiethnic populations via dysregulations in amino acid and drug metabolism. Larger investigations in multiethnic populations are required to elucidate the potential PFAS contribution to metabolic alterations and T2D risk. Funding: National Institutes of Health (R01ES033688, P30ES023515, R21ES035148, R35ES030435, R01ES032242, R01ES034521, R01ES029944, R01ES030364, U01HG013288, R21ES037112 and P30ES007048).http://www.sciencedirect.com/science/article/pii/S2352396425002828ExposomicsType 2 diabetesPer-and polyfluoroalkyl substancesMetabolomicsExposure mixture
spellingShingle Vishal Midya
Meizhen Yao
Elena Colicino
Dinesh Barupal
Xiangping Lin
Chris Gennings
Leda Chatzi
Veronica Wendy Setiawan
Ruth J.F. Loos
Ryan W. Walker
Douglas I. Walker
Damaskini Valvi
Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
EBioMedicine
Exposomics
Type 2 diabetes
Per-and polyfluoroalkyl substances
Metabolomics
Exposure mixture
title Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
title_full Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
title_fullStr Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
title_full_unstemmed Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
title_short Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US populationResearch in context
title_sort exposure to per and poly fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic us populationresearch in context
topic Exposomics
Type 2 diabetes
Per-and polyfluoroalkyl substances
Metabolomics
Exposure mixture
url http://www.sciencedirect.com/science/article/pii/S2352396425002828
work_keys_str_mv AT vishalmidya exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT meizhenyao exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT elenacolicino exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT dineshbarupal exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT xiangpinglin exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT chrisgennings exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT ledachatzi exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT veronicawendysetiawan exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT ruthjfloos exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT ryanwwalker exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT douglasiwalker exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext
AT damaskinivalvi exposuretoperandpolyfluoroalkylsubstancesinassociationtolateroccurrenceoftype2diabetesandmetabolicpathwaydysregulationinamultiethnicuspopulationresearchincontext